Search filters

List of works by Paul Lorigan

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial ⬇️

scientific article published on 23 July 2018

35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin a

article by Corinne Faivre-Finn et al published August 2007 in Lung Cancer

510 POSTER Phase I study of IMGN901 (BB-10901) in patients with CD56-positive solid tumours

A Guideline for the Management of Gastrointestinal Stromal Tumour (GIST).

scientific article published on January 2002

A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

scientific article

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

article

A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer.

scientific article

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology

article

A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre

scientific article published on 10 October 2007

A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue

scientific article published on 2 May 2010

A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update

scientific article published on 12 November 2008

A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.

scientific article

Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations

article

Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma

Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI)

scientific article published on 03 December 2020

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries

scientific article published on 31 October 2018

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

scientific article published on 15 April 2018

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

scholarly article by P G Corrie et al published 1 August 2018 in Annals of Oncology

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

scientific article published on 01 December 2019

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

scientific article published on 15 April 2014

Adjuvant immunotherapy: the sting in the tail

scientific article published on 05 May 2020

Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma

scientific article published on 9 December 2003

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis

scientific article published on 07 July 2017

Advances in the management of melanoma: targeted therapy, immunotherapy and future directions ⬇️

scientific article published on November 1, 2012

Advances in the treatment of late stage melanoma

scientific article published on 4 March 2013

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

scientific article published on 20 December 2018

Anti-Angiogenesis Therapy for Melanoma

Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient

scientific article

Anti-PD1 treatment of advanced melanoma: development of criteria for a safe stop

scientific article published on 01 July 2019

Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

scientific article published on 29 December 2015

Applying Best–Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer

Assessing the impact of diagnosis and the related supportive care needs in patients with cutaneous melanoma.

scientific article published on 5 September 2014

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 02 January 2020

Asthma in pregnancy complicated by iatrogenic pulmonary oedema.

scientific article published on June 1989

Authors' reply to Bayley and Cave

scientific article published in the British Medical Journal

Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab

scientific article published on 8 February 2018

BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling

scientific article published on 25 March 2014

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

scientific article

Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

scientific article published on 19 December 2011

Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma

scientific article published on 6 December 2012

Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma

scientific article published on 01 August 2020

Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

scientific article published on 26 May 2016

Characteristics of women with recurrent molar pregnancies.

scientific article

Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients

scientific article

Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer

scientific article published on June 1, 1995

Circulating tumor DNA predicts survival in patients with resected high risk stage II/III melanoma.

scientific article published on 3 November 2017

Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance

scientific article

Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine

article

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study

scholarly article published in March 2024

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial ⬇️

scientific article published on 19 June 2017

Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals

article

Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers

scientific article

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.

scientific article

Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma

scientific article

Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma

scientific article published on February 2001

Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]

scientific article published on 13 March 2018

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

scientific article published on 28 February 2022

Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer

scientific article published on 10 July 2019

Current drug treatment guidelines for epithelial ovarian cancer

scientific article published on April 1996

Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement

scientific article published on 28 June 2019

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

scientific article published on 24 February 2014

Dabrafenib and its use in the treatment of metastatic melanoma.

scientific article published on 10 August 2015

Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery

scientific article published on 25 September 2014

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA.

scientific article published on 08 August 2016

Does Adjuvant Vaccine Therapy Really Have Activity in Malignant Melanoma?

Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis

scientific article published on 15 September 2017

Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

scientific article published on 3 April 2012

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

scientific article published on 7 November 2016

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20).

scientific article published on 13 August 2013

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

scientific article published on 28 April 2016

Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

scientific article published on 15 June 2019

Efficacy of positron emission tomography staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting

scientific article published in October 2012

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

scientific article published on 7 December 2017

Emergency ambulatory outpatient management of immune-mediated hypophysitis

scientific article published on 20 June 2020

Emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomes

scientific article published on 23 October 2018

Emergency presentations in patients treated with immune checkpoint inhibitors

scientific article published on 27 March 2020

Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish

scientific article published on 12 March 2019

Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR

scientific article published on June 2015

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

scientific article published in 2023

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

scientific article published on 23 July 2009

Expanded access programmes: patient interests versus clinical trial integrity

scientific article published on 29 December 2014

Extensive-stage small-cell lung cancer--moving beyond response rate?

article

Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer

scientific article published on October 2002

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

scientific article published on 30 November 2015

Gender and survival in malignant tumours.

scientific article

Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA

scientific article published on 01 June 1996

Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor

scientific article published in August 2000

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

scientific article

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia

scientific article published on September 2005

High-risk cutaneous melanoma follow-up: time for more intensive surveillance?

scientific article published on 01 August 2014

Hyponatraemia secondary to nivolumab-induced primary adrenal failure.

scientific article published on November 2016

Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization

scientific article published on February 2002

Identifying melanomas in primary care: can we do better? ⬇️

scientific article published in the British Medical Journal

Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy

scientific article published on 10 February 2020

Immunotherapy: Does adjuvant ipilimumab have little adverse effect on quality of life?

scientific article published on 25 April 2017

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

scientific article (publication date: 19 August 2010)

Improved overall survival in melanoma with combined dabrafenib and trametinib

scientific article

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

scientific article

Improving Survival with Thoracic Radiotherapy in Patients with Small Cell Lung Cancer. The CONVERT and the REST Trials

Improving outcomes in advanced malignant melanoma: update on systemic therapy

scientific article (publication date: 2005)

Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma

scientific article published on 14 December 2012

Integrating radiation therapy with emerging systemic therapies: Lessons from a patient with cerebral radionecrosis, spinal cord myelopathy, and radiation pneumonitis.

scientific article

Investigation of female survival benefit in metastatic melanoma

scientific article published on August 1999

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

scientific article

LBA3_PRA PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF NIVOLUMAB (ANTI-PD-1; BMS-936558; ONO-4538) VERSUS INVESTIGATOR'S CHOICE CHEMOTHERAPY (ICC) IN PATIENTS WITH ADVANCED MELANOMA AFTER PRIOR ANTI-CTLA-4 THERAPY

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.

scientific article published on 8 March 2014

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

scientific article published on 18 September 2020

Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue

scientific article published on 13 April 2007

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review

scientific article

Lung cancer after treatment for breast cancer

scientific article published on 10 June 2010

MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy

scientific article published in July 1995

Management of Chronic Hypotony following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma

Management of small cell lung cancer: recent developments for optimal care

scientific article published on March 2012

Management of small-cell lung cancer

scientific article

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone

scientific article

Melanoma vaccines--they should work.

scientific article

Modern management of small-cell lung cancer

scientific article published on January 2007

Monitoring tumour cells in the peripheral blood of small cell lung cancer patients

scientific article

Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells

scientific article published on 9 November 2016

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

scientific article

No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients

scientific article published on 15 August 2014

Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism?

scientific article published on January 2006

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

scientific article published on April 2009

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic

O-153 Phase III randomised trial of doxorubicin based chemotherapy compared with platinum based chemotherapy in both limited and extensive stage patients

O-90 Randomised phase III trial of docetaxel/carboplatin vs. MIC/MVP chemotherapy in inoperable advanced non-small cell lung cancer (NSCLC) — A British thoracic oncology group (BTOG) trial

Oestrogenic Steroids and Melanoma Cell Interaction with Adjacent Skin Cells Influence Invasion of Melanoma Cells In Vitro

scientific article published on 01 January 2000

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial

scientific article published on 19 October 2011

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

scientific article published in January 2017

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

article

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis

scientific article

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

scientific article

PD-L1 expression as a potential predictive biomarker

scientific article published on 01 October 2015

Palliative treatment

scientific article published on April 2004

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma

article

Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma

scientific article

Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial.

scientific article published on 2 February 2018

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).

scientific article

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

scientific article published on 22 July 2019

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial

scientific article published on May 2007

Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.

scientific article

Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease

scientific article published on 3 October 2016

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

scientific article published on 9 March 2016

Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

scientific article published on 29 August 2013

Phase II Pilot Study of Intravenous High-Dose Interferon With or Without Maintenance Treatment in Melanoma at High Risk of Recurrence

scientific article published on 16 December 2013

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

scientific article

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

scientific article published on 12 September 2006

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer

scientific article

Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma

scientific article published on May 2003

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

article by Tim Eisen et al published April 2009 in Lung Cancer

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

scientific article published on 19 January 2010

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

scientific article published on 25 July 2016

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

article

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

scientific article published on August 2008

Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma

scientific article

Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer

scientific article

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

scientific article published on 23 November 2017

Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patients

Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells

scientific article

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

scientific article published on 01 May 2019

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma

scientific article published on 31 July 2014

Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma

scientific article

Prise en charge du cancer bronchique à petites cellules (CPC) (localisé et étendu)

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

scientific article published on 11 June 2019

Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with lim

scientific article published on 20 January 2016

Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate

scientific article

Radiotherapy for small-cell lung cancer-Where are we heading?

scientific article published on 03 August 2008

Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.

scientific article

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group

scientific article

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma

scientific article published on July 2003

Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer

scientific article published on 14 February 2005

Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer

scientific article

Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer

scientific article published in May 2005

Re: Small Cell Lung Cancer Treated in Southeast Wales, Lester et al., Clin Oncol 2006;18:378–382

scientific article published on 01 November 2006

Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study

scientific article

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

scientific article published in January 2018

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

scientific article published on 21 March 2017

Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).

scientific article published in October 2017

Revised U.K. guidelines for the management of cutaneous melanoma 2010

scientific article published on 01 July 2010

Revised UK guidelines for the management of cutaneous melanoma 2010

scientific article published on 21 August 2010

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.

scientific article

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 30 September 2019

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 21 August 2019

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study

scientific article

Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase.

scientific article

Sequential immunotherapy regimens—expect the unexpected

scientific article published on 04 June 2016

Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer

scientific article

Small Cell Lung Cancer (SCLC); any progress?

Small cell carcinoma of the cervix

scientific article published on 01 January 1996

Sodium salicylate inhibits TNF-alpha-induced NF-kappaB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells

scientific article published in February 2006

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

scientific article

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

scholarly article published on 1 April 2022

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

scientific article published on 11 April 2022

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

scientific article published on 12 February 2020

Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma

scientific article published on January 2016

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

scientific article published on 31 January 2014

Surrogate endpoints in advanced sarcoma trials: a meta-analysis

scientific article published on 02 October 2018

Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis

scientific article

Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019

scientific article published on 13 March 2020

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

scientific article published on 17 December 2015

Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.

scientific article

Survival of patients with early invasive melanoma down-staged under the new 8th AJCC edition.

scientific article published on 16 April 2018

Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma

scientific article

Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?

scientific article published on 27 February 2008

TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes

scientific article published on September 2003

Tarceva in relapsed non-small cell lung cancer: experience from Northwest England

article

Targeting angiogenesis in melanoma

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.

scientific article published on 22 February 2018

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

scientific article published on 01 March 1999

The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival

scientific article published on 02 July 2021

The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.

scientific article

The place of PD-1 inhibitors in melanoma management

scientific article

The role for chemotherapy in the modern management of melanoma

scientific article published on 19 May 2017

The role of chemotherapy in the modern management of melanoma

The role of nivolumab in melanoma

scientific article published on 12 January 2018

The role of positron emission tomography in management of small cell lung cancer

scientific article published on 27 April 2011

The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit

scientific article

Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.

scientific article

Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions

scientific article

Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments

scientific article

Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).

scientific article published on 27 June 2012

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study

scientific article

Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma

scientific article published on 9 January 2018

Update on targeted therapies for small cell carcinoma of the lung

Urgent treatment of patients with metastatic melanoma using Braf inhibitors in the absence of Braf mutation status

scientific article published on 23 April 2013

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial

scientific article

VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma

scientific article published on 01 April 2000

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

scientific article

Vemurafenib-induced nonautoimmune haemolytic anaemia

article published in 2014

Paulina is supported by:

About Paulina

Help